Welcome to our dedicated page for Astronova SEC filings (Ticker: ALOT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AstroNova, Inc. (NASDAQ: ALOT) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries that help explain key points for investors. AstroNova is a Rhode Island corporation listed on the NASDAQ Global Market, and it files annual, quarterly and current reports, proxy statements and other documents with the U.S. Securities and Exchange Commission.
Through this page, users can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe AstroNova’s Product Identification and Aerospace segments, risk factors, credit facilities, non-GAAP metrics and overall financial condition. These filings detail how the company’s digital product identification solutions and aerospace printing, avionics and data acquisition products contribute to its results, and they explain management’s use of measures such as Adjusted EBITDA and segment-level non-GAAP operating income.
Investors can also access current reports on Form 8-K that disclose material events, including amendments to the company’s Amended and Restated Credit Agreement with Bank of America, leadership changes, cooperation agreements with shareholders, board appointments and the outcomes of annual shareholder meetings. For example, 8-K filings describe the Sixth Amendment to the credit agreement, the appointment of a new President and Chief Executive Officer, and the Cooperation Agreement with Askeladden Capital Management LLC.
AstroNova’s proxy materials on Schedule 14A provide detail on corporate governance, board composition, executive compensation and shareholder proposals. These documents outline features such as one-share, one-vote, board independence, committee structures and advisory votes on executive pay and auditor ratification.
Stock Titan’s interface surfaces these filings in real time as they are posted to EDGAR and applies AI analysis to highlight important sections, summarize complex credit agreement terms, and clarify the implications of leadership or governance changes. Users can also review ownership and transaction-related filings, such as Forms 3, 4 and 5 when available, to track insider holdings and changes.
By using this page, investors gain a structured view of AstroNova’s regulatory history, from its financial reporting and non-GAAP reconciliations to its capital structure, covenants and board-level decisions, with AI tools that make lengthy documents more accessible.
AstroNova, Inc. (ALOT) reported interim filing details showing financing, segment and expense updates for the periods ended July 31, 2025 and August 3, 2024. The Product ID segment derives approximately 80% of its revenue from recurring supplies, parts and service. Fair-value estimates for acquired intangibles used a 0.75% relief-from-royalty rate and a 15.5% discount rate for trademark valuation. Credit agreements were amended to temporarily increase the revolving facility to $30.0 million until January 31, 2025, and the company borrowed EUR 14.0 million on a Term A-2 loan plus amounts under the revolving facility to fund a purchase. The Term A-2 loan requires quarterly principal payments through April 30, 2027 and a full payment on August 4, 2027. Interest rates on facilities vary by leverage, with EURIBOR-based margins of 1.60%–2.85%; other borrowing includes an equipment loan at 7.06% (monthly payments of $16,296 through Jan 23, 2029) and an MTEX term loan at 6.022% with monthly payments of EUR 17,402 ($18,795) through Dec 21, 2033. The company expects $3.0 million of annualized savings from restructuring actions. For six months, selling and marketing expense declined to $11.3 million (down 8.9%), G&A rose to $10.0 million (up 18.0%) including nonrecurring charges, and R&D was $3.1 million (4.2% of revenue). Equity plan and director compensation amendments and outstanding share counts are described; employees delivered 2,739 shares to cover taxes on vesting at an average market value of $9.01 per share.
AstraNova, Inc. filed a current report to let investors know it has released financial results for its fiscal second quarter ended July 31, 2025. On September 9, 2025, the company issued a press release with these quarterly results, which is included as Exhibit 99.1 to the report and incorporated by reference.
The company notes that the earnings information in this report and in the attached press release is being furnished rather than filed, which limits how it is treated under certain securities law liability provisions and how it may be incorporated into other SEC filings.
AstroNova, Inc. (ALOT) reporting person Padraig Finn received 43,591 restricted stock units (RSUs) on 08/15/2025. Each RSU represents a contingent right to one share of common stock and is scheduled to vest and settle on 08/15/2028. The reported RSUs show 43,591 shares beneficially owned following the transaction and are held directly. The filing was signed by Daniel Clevenger by power of attorney on 09/08/2025.
AstroNova, Inc. (ALOT) director Richard S. Warzala received a restricted stock award of 3,471 shares on 08/28/2025 under the company's Amended and Restated Non-Employee Director Annual Compensation Program. The award was reported as having a price of $0 (restricted grant), and after the transaction the reporting person beneficially owned 67,866 shares. The Form 4 was signed by power of attorney on 09/02/2025. The filing reflects a routine, compensatory equity grant to a non-employee director and does not disclose cash consideration or derivative transactions.
Yvonne Schlaeppi, a director of AstroNova, Inc. (ALOT), received a restricted stock award of 3,196 shares on 08/28/2025 under the Amended and Restated Non-Employee Director Annual Compensation Program. The shares were granted at a price of $0 and, after the award, the reporting person beneficially owned 44,426.954 shares. The Form 4 was signed by Daniel Clevenger by power of attorney on 09/02/2025. The filing documents a routine, non-derivative equity grant to a director as part of standard board compensation.
AstroNova, Inc. (ALOT) director Quain Mitchell I received a restricted stock award of 3,346 shares on 08/28/2025 under the companys Amended and Restated Non-Employee Director Annual Compensation Program. The shares were issued at a price of $0 as restricted compensation. After the grant, the reporting person beneficially owns 101,065 shares directly and 16,701 shares indirectly through a trust where they serve as trustee. The Form 4 was signed by power of attorney on 09/02/2025. The filing documents a routine director equity grant as part of non-employee director pay.
AstroNova, Inc. (ALOT) director Alexis P. Michas received a restricted stock award totaling 3,071 shares on 08/28/2025 under the Amended and Restated Non-Employee Director Annual Compensation Program. After the award, Mr. Michas directly held 21,826 shares. The filing discloses that 535,203 shares are beneficially owned indirectly by Juniper Targeted Opportunity Fund, L.P., for which Mr. Michas is a managing member of the investment manager and may be deemed to beneficially own the fund's holdings; he disclaims ownership except to the extent of his pecuniary interest. The Form 4 was signed by power of attorney on 09/02/2025.
AstroNova, Inc. (ALOT) director Shawn W. Kravetz was granted 2,318 shares of common stock as a restricted stock award under the Amended and Restated Non-Employee Director Annual Compensation Program. The acquisition transaction date is 08/28/2025, reported on a Form 4 filed for one reporting person. The transaction is coded as an acquisition at a price of $0, and the Form shows the reporting person beneficially owned 2,318 shares following the award. The Form 4 was signed by Daniel Clevenger by power of attorney on 09/02/2025.
AstroNova, Inc. director Shawn W. Kravetz filed a Form 3 stating that he beneficially owns no securities of the company. The filing identifies him as a director of AstroNova, Inc. (ticker ALOT) with an event date of August 21, 2025, and notes an Exhibit 24 Power of Attorney authorizing the signature.
AstroNova, Inc. informs shareholders that its 2025 Annual Meeting was rescheduled to Tuesday, December 2, 2025. The company set October 13, 2025 as the record date for shareholders entitled to vote at that meeting. AstroNova states that shareholder proposals to be included in the company’s proxy materials must be received in writing at the Company’s Secretary at 600 East Greenwich Avenue, West Warwick, Rhode Island 02893 by the close of business on October 3, 2025, which the company deems a reasonable deadline under applicable Exchange Act rules. The notice reminds shareholders that proposals and director nominations must also comply with Rhode Island law and SEC rules, and that submissions received after the stated deadline will be considered untimely and not included in the proxy materials or considered at the meeting. The company says the definitive proxy will specify the meeting time, location and means of attendance.